Search

Edward L. Coles

Examiner (ID: 14949)

Most Active Art Unit
2602
Art Unit(s)
2722, 2507, 2609, 2622, 2607, 2304, 2608, 2603, 2101, 2602, 2612, 2625, 2506, 2616, 3103
Total Applications
1012
Issued Applications
912
Pending Applications
1
Abandoned Applications
99

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 3451260 [patent_doc_number] => 05378464 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-01-03 [patent_title] => 'Modulation of inflammatory responses by administration of GMP-140 or antibody to GMP-140' [patent_app_type] => 1 [patent_app_number] => 7/320408 [patent_app_country] => US [patent_app_date] => 1989-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12409 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/378/05378464.pdf [firstpage_image] =>[orig_patent_app_number] => 320408 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/320408
Modulation of inflammatory responses by administration of GMP-140 or antibody to GMP-140 Mar 7, 1989 Issued
07/314995 ENERGY TRANSFER HYBRRIDIZATION ASSAY USING INTERCALATORS AND LANTHANIDE METALS Feb 23, 1989 Abandoned
Array ( [id] => 3521696 [patent_doc_number] => 05503841 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-02 [patent_title] => 'Human IL-2 as a vaccine adjuvant' [patent_app_type] => 1 [patent_app_number] => 7/314975 [patent_app_country] => US [patent_app_date] => 1989-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 4530 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/503/05503841.pdf [firstpage_image] =>[orig_patent_app_number] => 314975 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/314975
Human IL-2 as a vaccine adjuvant Feb 23, 1989 Issued
Array ( [id] => 3494681 [patent_doc_number] => 05508291 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-16 [patent_title] => 'Feline interferon' [patent_app_type] => 1 [patent_app_number] => 7/291597 [patent_app_country] => US [patent_app_date] => 1988-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6559 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/508/05508291.pdf [firstpage_image] =>[orig_patent_app_number] => 291597 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/291597
Feline interferon Dec 28, 1988 Issued
Array ( [id] => 2880957 [patent_doc_number] => 05108890 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-04-28 [patent_title] => 'Chromogenic compounds, processes for the preparation thereof and use thereof as enzyme substrates' [patent_app_type] => 1 [patent_app_number] => 7/175858 [patent_app_country] => US [patent_app_date] => 1988-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12530 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/108/05108890.pdf [firstpage_image] =>[orig_patent_app_number] => 175858 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/175858
Chromogenic compounds, processes for the preparation thereof and use thereof as enzyme substrates Mar 30, 1988 Issued
Menu